Delivery Order SPE2DB24D1021-SPE2DB24FETGF

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $4,711.56 firm-fixed-price delivery order contract is for the supply of 100 count bottles of 8 mg Hydromorphone HCL extended-release tablets. The contract has an ultimate completion date of August 30, 2024 and was awarded on August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,143.85, is for the delivery of 100 tablets of 8 mg hydromorphone hydrochloride extended-release. It is a firm fixed-price delivery order contract with an ultimate completion date of January 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $4,010.30, is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets in quantities of 100. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,927.70, is a Delivery Order for 32mg Hydromorphone HCl Extended Release Tablets. The contract has an ultimate completion date of January 7, 2025 and is a Firm Fixed Price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order worth $1,481.33 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for hydromorphone hydrochloride extended-release 16 mg tablets, a critical pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $8,603.00 Firm Fixed Price Delivery Order is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets. The award appears to be under a larger Indefinite Delivery Contract (IDC) vehicle that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,030.82, is for the delivery of hydromorphone 1 mg/ml vials. The contract has a completion date of March 5, 2024 and is a firm fixed-price arrangement. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,302.24, is for the delivery of Hydromorphone HCL ER Tablets 12mg. This is a firm fixed-price delivery order contract with an ultimate completion date of January 22, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,923.51, is for the delivery of 4562535552 - Hydromorphone HCL ER Tabs 12mg, a pain management medication. The contract has an ultimate completion date of October 20, 2023 and is a Firm Fixed Price Delivery Order. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,383.90 firm-fixed-price delivery order is for the supply of 4,566,640,143 tablets of 16 mg hydromorphone hydrochloride extended-release tablets. The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB24FETGF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 counts of 8 mg Hydromorphone Hydrochloride Extended Release tablets. The contract has a firm fixed price of $2,512.23 and a completion date of August 9, 2024. The award is not designated as a set-aside contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.

Generated 11/7/24, 9:16 AM